Home/All Molecules/Salbutamol

Salbutamol Range

Comprehensive Salbutamol portfolio for Franchise & Manufacturing.

Category
salbutamol
Total Formulations
32
Available Forms
Capsule, Drop, Inhaler, Rota Cap, Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Salbutamol portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Salbutamol batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Salbutamol PCD Pharma Franchise

Salbutamol PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Salbutamol PCD pharma franchise company offering a portfolio of 32 Salbutamol formulations across inhalers, rotacaps, tablets, capsules, syrup and respirator drops. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Salbutamol?

Salbutamol (albuterol) is a short-acting selective beta-2 adrenergic agonist. It stimulates beta-2 receptors on airway smooth muscle, raising intracellular cyclic AMP and producing rapid bronchodilation, usually within minutes of inhalation. The compound record can be reviewed on PubChem.

Therapeutic Applications

Relief of acute bronchospasm in asthma and chronic obstructive pulmonary disease, exercise-induced bronchoconstriction, and as rescue therapy in acute exacerbations. It is also combined with ipratropium, theophylline or guaiphenesin in oral and respiratory formats.

Prescribed by: Pulmonologists, chest physicians, paediatricians, general physicians and emergency practitioners prescribe Salbutamol across all age groups.

Why Salbutamol is a High-Potential Molecule for Distributors

Salbutamol is the reliever every asthma and COPD patient is expected to carry, which makes it one of the highest-repeat respiratory molecules in the country. India has a very large asthma and COPD population, and pollution-driven exacerbations sustain demand well beyond the seasonal peaks. With 32 formulations spanning inhalers, rotacaps, tablets, syrup and respirator solution, a distributor can serve paediatric, adult and hospital demand from one molecule and use it as the anchor of an entire respiratory division.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Salbutamol franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Salbutamol business in your region.

References

  1. PubChem – Salbutamol compound record, US National Library of Medicine
  2. PubMed – clinical literature on Salbutamol, NCBI
  3. WHO Model List of Essential Medicines

Aceclofenac in Modern Clinical Practice

Our formulations of Salbutamol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Salbutamol in PCD Franchise

Start Your Salbutamol Franchise with Cafoli Lifecare

Ready to take monopoly rights for Salbutamol in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 32 Salbutamol formulations in inhalers, rotacaps, tablets, capsules, syrup and respirator drops. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Salbutamol range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Pulmonologists, chest physicians, paediatricians, general physicians and emergency practitioners prescribe Salbutamol across all age groups.

Inhalers and rotacaps carry the bulk of chronic asthma and COPD demand because they are the guideline-preferred reliever route, while syrup and paediatric formats drive volume in childrens practice and respirator solution moves through hospitals and nebulisation clinics. Most distributors find they need all three groups to serve a territory fully, which is why the 32-formulation range is a practical advantage.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Salbutamol franchise agreement and monopoly allotment can be processed.